This review describes the current understanding of bronchiolitis, including the increasing number of viruses that are known to cause it, the current understanding of its pathogenesis, the importance ...

CXCL12 and CXCL13 are potential biomarkers for RSV bronchiolitis severity and recurrence risk, with elevated levels indicating severe cases and recurrent wheezing, respectively. RSV remains a major ...

We're still in flu season, and one common illness for infants and children this time of year is bronchiolitis. Kevin R. Murphy, M.D., is board certified in pediatrics. Learn more about Kevin on the ...

A single dose of the long-acting antibody nirsevimab to infants can halve hospitalizations for bronchiolitis. This is the result of a study involving the Università Cattolica del Sacro Cuore, Rome ...

Bronchiolitis remains a leading cause of hospitalisation among infants and young children, prompting continuous efforts to optimise management strategies. Recent clinical approaches focus on ...

Infants given acetaminophen (also called paracetamol; brand name, Tylenol) for pain or fever relief in their first year were ...

Constrictive bronchiolitis obliterans is an important respiratory illness because of its underlying irreversible fibrotic process, and is defined as concentric fibrosis in the bronchiolar submucosal ...

RSV might sound like just another cold virus, but for babies and young kids, it can turn serious fast. Here's what you need to know to spot it early, manage symptoms, and keep your tiny CEO safe. RSV ...

Ziresovir significantly improved clinical outcomes and reduced RSV viral load in infants compared to placebo in a phase 3 trial. The trial involved infants aged 1 to 24 months, with ziresovir showing ...

Add Yahoo as a preferred source to see more of our stories on Google. Though such symptoms are uncomfortable for everyone, they can be more serious in babies, young children, the elderly and the ...

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug has been approved at the European level to protect infants in their first ...